Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel O Antwi

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Pancreas|February 10, 2018
Leukocyte Telomere Length and Pancreatic Cancer Risk: Updated Epidemiologic ReviewSamuel O Antwi, Gloria M Petersen
Hepatology (Baltimore, Md.)|August 22, 2023
Geospatial analysis of cyanobacterial exposure and liver cancer in the contiguous United StatesMatthew Ledenko, Samuel O Antwi, Tushar Patel
Annals of Hepatology|June 13, 2018
Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014Samuel O Antwi, Omar Y Mousa, Tushar Patel
Cancers|October 14, 2022
Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric CancerPengcheng Sun, Samuel O Antwi, Kurt Sartorius, et al.
The American Journal of Gastroenterology|October 13, 2023
Racial Disparities in Liver Disease Mortality Trends Among Black and White Populations in the United States, 1999-2020: An Analysis of CDC WONDER DatabaseYichen Wang, Yuting Huang, Samuel O Antwi, et al.
Frontiers in Oncology|May 23, 2022
RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?Kurt Sartorius, Samuel O Antwi, Anil Chuturgoon, et al.
Journal of Clinical Gastroenterology|April 10, 2020
Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC DiagnosisSamuel O Antwi, Zhuo Li, Kabir Mody, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 28, 2019
Risk of <i>De Novo</i> Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis CSamuel O Antwi, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Journal of Hepatocellular Carcinoma|February 25, 2022
Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning ApproachJonathan Thomas, Linda M Liao, Rashmi Sinha, et al.
Cancers|December 23, 2022
Metabolic Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: A Prospective StudySamuel O Antwi, Emily C Craver, Yvonne A Nartey, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Pancreas|February 10, 2018
Leukocyte Telomere Length and Pancreatic Cancer Risk: Updated Epidemiologic ReviewSamuel O Antwi, Gloria M Petersen
Hepatology (Baltimore, Md.)|August 22, 2023
Geospatial analysis of cyanobacterial exposure and liver cancer in the contiguous United StatesMatthew Ledenko, Samuel O Antwi, Tushar Patel
Annals of Hepatology|June 13, 2018
Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014Samuel O Antwi, Omar Y Mousa, Tushar Patel
Cancers|October 14, 2022
Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric CancerPengcheng Sun, Samuel O Antwi, Kurt Sartorius, et al.
The American Journal of Gastroenterology|October 13, 2023
Racial Disparities in Liver Disease Mortality Trends Among Black and White Populations in the United States, 1999-2020: An Analysis of CDC WONDER DatabaseYichen Wang, Yuting Huang, Samuel O Antwi, et al.
Frontiers in Oncology|May 23, 2022
RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?Kurt Sartorius, Samuel O Antwi, Anil Chuturgoon, et al.
Journal of Clinical Gastroenterology|April 10, 2020
Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC DiagnosisSamuel O Antwi, Zhuo Li, Kabir Mody, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 28, 2019
Risk of <i>De Novo</i> Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis CSamuel O Antwi, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Journal of Hepatocellular Carcinoma|February 25, 2022
Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning ApproachJonathan Thomas, Linda M Liao, Rashmi Sinha, et al.
Cancers|December 23, 2022
Metabolic Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: A Prospective StudySamuel O Antwi, Emily C Craver, Yvonne A Nartey, et al.
Pageof 7